25/12/2013
NorthStar Awarded $21.8 Million for Domestic Molybdenum
Northstar Medical Technologies was awarded $21.8 million in part by the U.S. Department of Energy's National Nuclear Security Administration (NNSA). The grant was provided in an effort to develop a sustainable American supply of molybdenum-99 using alternative medical isotope production methods that do not require the use of high-enriched uranium, according to a Nov. 21 announcement.
For more information visit www.molecularimaging.net
